February 07, 2026

#amr — Saturday, February 07, 2026 (3 items)

hot top new

💬 0	Switch to fixed-dose doravirine (100 mg) and islatravir (0.25 mg) once daily in virologically suppressed adults with HIV-1 on bictegravir, emtricitabine, and tenofovir alafenamide: 48-week results of a phase 3, multicentre, randomised, controlled, double-blind, non-inferiority trial. (linkinghub.elsevier.com)	Colson AE … Lahoulou R The Lancet 2026-02-07	#amr #clinical trial #hiv
💬 0	Switch to fixed-dose doravirine (100 mg) and islatravir (0.25 mg) once daily in virologically suppressed adults with HIV-1 on oral antiretroviral therapy: 48-week results of a phase 3, multicentre, randomised, open-label, non-inferiority trial. (linkinghub.elsevier.com)	Orkin C … Kim J The Lancet 2026-02-07	#amr #clinical trial #hiv #virologic suppression
💬 0	PlasRAG: comprehensive plasmid characterization and retrieval through sequence-text alignment. (link.springer.com)	Ji Y … Sun Y Genome Biology 2026-02-07	#amr #sequencing #plasmid #annotation